TOP Group’s venture into healthcare services is backed by our fundamental belief that critical healthcare services should be widely accessible. Our latest involvement with Naleya Genomik Indonesia (NGI) is a testament to our commitment. NGI is a joint venture with BGI Genomics, and offers a variety of quality and affordable DNA-based screenings (including but not limited to newborn disease screening and early cancer risk detection).